ScholarIQanswers from OpenAlex

The combination of sirolimus and rosiglitazone produces a renoprotective effect on diabetic kidney disease in rats

PaperCitations, authors & open-access status

The combination of sirolimus and rosiglitazone produces a renoprotective effect on diabetic kidney disease in rats is a paper indexed in ScholarIQ from OpenAlex.

How many citations does The combination of sirolimus and rosiglitazone produces a renoprotective effect on diabetic kidney disease in rats have?

ScholarIQcitation count

The combination of sirolimus and rosiglitazone produces a renoprotective effect on diabetic kidney disease in rats has 28 citations in the OpenAlex counts ScholarIQ stores.

When was The combination of sirolimus and rosiglitazone produces a renoprotective effect on diabetic kidney disease in rats published?

ScholarIQyear

The combination of sirolimus and rosiglitazone produces a renoprotective effect on diabetic kidney disease in rats has 2010 year in the ScholarIQ index.

What is the open-access status of The combination of sirolimus and rosiglitazone produces a renoprotective effect on diabetic kidney disease in rats?

ScholarIQoa status

The combination of sirolimus and rosiglitazone produces a renoprotective effect on diabetic kidney disease in rats has closed oa status in the ScholarIQ index.

What is the DOI of The combination of sirolimus and rosiglitazone produces a renoprotective effect on diabetic kidney disease in rats?

ScholarIQdoi

The DOI for The combination of sirolimus and rosiglitazone produces a renoprotective effect on diabetic kidney disease in rats is on the source record.

What is the PMID of The combination of sirolimus and rosiglitazone produces a renoprotective effect on diabetic kidney disease in rats?

ScholarIQpmid

The PMID for The combination of sirolimus and rosiglitazone produces a renoprotective effect on diabetic kidney disease in rats is on the source record.

What is the OpenAlex record for The combination of sirolimus and rosiglitazone produces a renoprotective effect on diabetic kidney disease in rats?

ScholarIQopenalex

The OpenAlex for The combination of sirolimus and rosiglitazone produces a renoprotective effect on diabetic kidney disease in rats is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial